Industry: Chemical & Material
Published Date: 2024-04-10
Pages: 94 Pages
Report ld: 2873792
Request Sample
Customized Report
Imidazolinone API Market Size(US$)

CAGR 2024-2030
-1%
Market Size,2030
USD 184.9
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Imidazolinone API market is projected to grow from US$ 195.8 million in 2024 to US$ 184.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of -1.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
In terms of production side, this report researches the Imidazolinone API production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Imidazolinone API by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Imidazolinone API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Imidazolinone API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Imidazolinone API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Imidazolinone API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Imidazolinone API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Imidazolinone API sales, projected growth trends, production technology, application and end-user industry.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Imidazolinone API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Imidazolinone API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Imidazolinone API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Imidazolinone API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Imidazolinone API Product Introduction
1.2 Market by Type
1.2.1 Global Imidazolinone API Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Purity 98%
1.2.3 Purity 96%
1.3 Market by Application
1.3.1 Global Imidazolinone API Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Soybean
1.3.3 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Imidazolinone API Production
2.1 Global Imidazolinone API Production Capacity (2019-2030)
2.2 Global Imidazolinone API Production by Region: 2019 VS 2023 VS 2030
2.3 Global Imidazolinone API Production by Region
2.3.1 Global Imidazolinone API Historic Production by Region (2019-2024)
2.3.2 Global Imidazolinone API Forecasted Production by Region (2025-2030)
2.3.3 Global Imidazolinone API Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Imidazolinone API Revenue Estimates and Forecasts 2019-2030
3.2 Global Imidazolinone API Revenue by Region
3.2.1 Global Imidazolinone API Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Imidazolinone API Revenue by Region (2019-2024)
3.2.3 Global Imidazolinone API Revenue by Region (2025-2030)
3.2.4 Global Imidazolinone API Revenue Market Share by Region (2019-2030)
3.3 Global Imidazolinone API Sales Estimates and Forecasts 2019-2030
3.4 Global Imidazolinone API Sales by Region
3.4.1 Global Imidazolinone API Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Imidazolinone API Sales by Region (2019-2024)
3.4.3 Global Imidazolinone API Sales by Region (2025-2030)
3.4.4 Global Imidazolinone API Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Imidazolinone API Sales by Manufacturers
4.1.1 Global Imidazolinone API Sales by Manufacturers (2019-2024)
4.1.2 Global Imidazolinone API Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Imidazolinone API in 2023
4.2 Global Imidazolinone API Revenue by Manufacturers
4.2.1 Global Imidazolinone API Revenue by Manufacturers (2019-2024)
4.2.2 Global Imidazolinone API Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Imidazolinone API Revenue in 2023
4.3 Global Imidazolinone API Sales Price by Manufacturers
4.4 Global Key Players of Imidazolinone API, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Imidazolinone API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Imidazolinone API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Imidazolinone API, Product Offered and Application
4.8 Global Key Manufacturers of Imidazolinone API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Imidazolinone API Sales by Type
5.1.1 Global Imidazolinone API Historical Sales by Type (2019-2024)
5.1.2 Global Imidazolinone API Forecasted Sales by Type (2025-2030)
5.1.3 Global Imidazolinone API Sales Market Share by Type (2019-2030)
5.2 Global Imidazolinone API Revenue by Type
5.2.1 Global Imidazolinone API Historical Revenue by Type (2019-2024)
5.2.2 Global Imidazolinone API Forecasted Revenue by Type (2025-2030)
5.2.3 Global Imidazolinone API Revenue Market Share by Type (2019-2030)
5.3 Global Imidazolinone API Price by Type
5.3.1 Global Imidazolinone API Price by Type (2019-2024)
5.3.2 Global Imidazolinone API Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Imidazolinone API Sales by Application
6.1.1 Global Imidazolinone API Historical Sales by Application (2019-2024)
6.1.2 Global Imidazolinone API Forecasted Sales by Application (2025-2030)
6.1.3 Global Imidazolinone API Sales Market Share by Application (2019-2030)
6.2 Global Imidazolinone API Revenue by Application
6.2.1 Global Imidazolinone API Historical Revenue by Application (2019-2024)
6.2.2 Global Imidazolinone API Forecasted Revenue by Application (2025-2030)
6.2.3 Global Imidazolinone API Revenue Market Share by Application (2019-2030)
6.3 Global Imidazolinone API Price by Application
6.3.1 Global Imidazolinone API Price by Application (2019-2024)
6.3.2 Global Imidazolinone API Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Imidazolinone API Market Size by Type
7.1.1 US & Canada Imidazolinone API Sales by Type (2019-2030)
7.1.2 US & Canada Imidazolinone API Revenue by Type (2019-2030)
7.2 US & Canada Imidazolinone API Market Size by Application
7.2.1 US & Canada Imidazolinone API Sales by Application (2019-2030)
7.2.2 US & Canada Imidazolinone API Revenue by Application (2019-2030)
7.3 US & Canada Imidazolinone API Sales by Country
7.3.1 US & Canada Imidazolinone API Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Imidazolinone API Sales by Country (2019-2030)
7.3.3 US & Canada Imidazolinone API Revenue by Country (2019-2030)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Imidazolinone API Market Size by Type
8.1.1 Europe Imidazolinone API Sales by Type (2019-2030)
8.1.2 Europe Imidazolinone API Revenue by Type (2019-2030)
8.2 Europe Imidazolinone API Market Size by Application
8.2.1 Europe Imidazolinone API Sales by Application (2019-2030)
8.2.2 Europe Imidazolinone API Revenue by Application (2019-2030)
8.3 Europe Imidazolinone API Sales by Country
8.3.1 Europe Imidazolinone API Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Imidazolinone API Sales by Country (2019-2030)
8.3.3 Europe Imidazolinone API Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Imidazolinone API Market Size by Type
9.1.1 China Imidazolinone API Sales by Type (2019-2030)
9.1.2 China Imidazolinone API Revenue by Type (2019-2030)
9.2 China Imidazolinone API Market Size by Application
9.2.1 China Imidazolinone API Sales by Application (2019-2030)
9.2.2 China Imidazolinone API Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Imidazolinone API Market Size by Type
10.1.1 Asia Imidazolinone API Sales by Type (2019-2030)
10.1.2 Asia Imidazolinone API Revenue by Type (2019-2030)
10.2 Asia Imidazolinone API Market Size by Application
10.2.1 Asia Imidazolinone API Sales by Application (2019-2030)
10.2.2 Asia Imidazolinone API Revenue by Application (2019-2030)
10.3 Asia Imidazolinone API Sales by Region
10.3.1 Asia Imidazolinone API Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Imidazolinone API Revenue by Region (2019-2030)
10.3.3 Asia Imidazolinone API Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Imidazolinone API Market Size by Type
11.1.1 Middle East, Africa and Latin America Imidazolinone API Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Imidazolinone API Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Imidazolinone API Market Size by Application
11.2.1 Middle East, Africa and Latin America Imidazolinone API Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Imidazolinone API Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Imidazolinone API Sales by Country
11.3.1 Middle East, Africa and Latin America Imidazolinone API Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Imidazolinone API Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Imidazolinone API Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 BASF
12.1.1 BASF Company Information
12.1.2 BASF Overview
12.1.3 BASF Imidazolinone API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 BASF Imidazolinone API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 BASF Recent Developments
12.2 ADAMA
12.2.1 ADAMA Company Information
12.2.2 ADAMA Overview
12.2.3 ADAMA Imidazolinone API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 ADAMA Imidazolinone API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 ADAMA Recent Developments
12.3 Nufarm
12.3.1 Nufarm Company Information
12.3.2 Nufarm Overview
12.3.3 Nufarm Imidazolinone API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Nufarm Imidazolinone API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Nufarm Recent Developments
12.4 Shandong CYNDA (Group) Co., Ltd.
12.4.1 Shandong CYNDA (Group) Co., Ltd. Company Information
12.4.2 Shandong CYNDA (Group) Co., Ltd. Overview
12.4.3 Shandong CYNDA (Group) Co., Ltd. Imidazolinone API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Shandong CYNDA (Group) Co., Ltd. Imidazolinone API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Shandong CYNDA (Group) Co., Ltd. Recent Developments
12.5 Jiangsu Yangnong Chemical Co., Ltd.
12.5.1 Jiangsu Yangnong Chemical Co., Ltd. Company Information
12.5.2 Jiangsu Yangnong Chemical Co., Ltd. Overview
12.5.3 Jiangsu Yangnong Chemical Co., Ltd. Imidazolinone API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Jiangsu Yangnong Chemical Co., Ltd. Imidazolinone API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Jiangsu Yangnong Chemical Co., Ltd. Recent Developments
12.6 Jiangsu Flag Chemical Industry Co., Ltd.
12.6.1 Jiangsu Flag Chemical Industry Co., Ltd. Company Information
12.6.2 Jiangsu Flag Chemical Industry Co., Ltd. Overview
12.6.3 Jiangsu Flag Chemical Industry Co., Ltd. Imidazolinone API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Jiangsu Flag Chemical Industry Co., Ltd. Imidazolinone API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Jiangsu Flag Chemical Industry Co., Ltd. Recent Developments
12.7 Jiangsu Changqing Agrochemical Co., Ltd.
12.7.1 Jiangsu Changqing Agrochemical Co., Ltd. Company Information
12.7.2 Jiangsu Changqing Agrochemical Co., Ltd. Overview
12.7.3 Jiangsu Changqing Agrochemical Co., Ltd. Imidazolinone API Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Jiangsu Changqing Agrochemical Co., Ltd. Imidazolinone API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Jiangsu Changqing Agrochemical Co., Ltd. Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Imidazolinone API Industry Chain Analysis
13.2 Imidazolinone API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Imidazolinone API Production Mode & Process
13.4 Imidazolinone API Sales and Marketing
13.4.1 Imidazolinone API Sales Channels
13.4.2 Imidazolinone API Distributors
13.5 Imidazolinone API Customers
14 Imidazolinone API Market Dynamics
14.1 Imidazolinone API Industry Trends
14.2 Imidazolinone API Market Drivers
14.3 Imidazolinone API Market Challenges
14.4 Imidazolinone API Market Restraints
15 Key Finding in The Global Imidazolinone API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Imidazolinone API was estimated to be worth US$ 192 million in 2025 and is projected to reach US$ 180 million, growing at a CAGR of -1.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 131
USD 3950.00
(Single User License)
The global Imidazolinone API market was valued at US$ 192 million in 2025 and is anticipated to reach US$ 180 million by 2032, at a CAGR of -1.0% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 126
USD 2900.00
(Single User License)
The global Imidazolinone API market size was US$ 194 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of -1.0% during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 78
USD 4250.00
(Single User License)
The global Imidazolinone API market is projected to grow from US$ 194 million in 2024 to US$ 182 million by 2031, at a CAGR of -1.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 150
USD 4900.00
(Single User License)
The global market for Imidazolinone API was estimated to be worth US$ 194 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of -1.0% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 98
USD 3950.00
(Single User License)
The global market for Imidazolinone API was valued at US$ 194 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of -1.0% during the forecast period.
Published Date: 2025-01-13
Pages: 88
USD 2900.00
(Single User License)
The global Imidazolinone API market was valued at US$ 206.9 million in 2023 and is anticipated to reach US$ 184.9 million by 2030, witnessing a CAGR of -1.0% during the forecast period 2024-2030.
Published Date: 2024-01-17
Pages: 87
USD 2900.00
(Single User License)
The global market for Imidazolinone API was estimated to be worth US$ 192 million in 2025 and is projected to reach US$ 180 million, growing at a CAGR of -1.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 131
The global Imidazolinone API market was valued at US$ 192 million in 2025 and is anticipated to reach US$ 180 million by 2032, at a CAGR of -1.0% from 2026 to 2032.
Published: 2026-04-18
Pages: 126
The global Imidazolinone API market size was US$ 194 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of -1.0% during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 78
The global Imidazolinone API market is projected to grow from US$ 194 million in 2024 to US$ 182 million by 2031, at a CAGR of -1.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 150
The global market for Imidazolinone API was estimated to be worth US$ 194 million in 2024 and is forecast to a readjusted size of US$ 182 million by 2031 with a CAGR of -1.0% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 98
The global market for Imidazolinone API was valued at US$ 194 million in the year 2024 and is projected to reach a revised size of US$ 182 million by 2031, growing at a CAGR of -1.0% during the forecast period.
Published: 2025-01-13
Pages: 88
The global Imidazolinone API market was valued at US$ 206.9 million in 2023 and is anticipated to reach US$ 184.9 million by 2030, witnessing a CAGR of -1.0% during the forecast period 2024-2030.
Published: 2024-01-17
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now